All In Biotech

Free tool

FAERS Monitor: Aleve Pm

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205352 or its brand name (Aleve Pm, Diphenhydramine Hydrochloride, Naproxen Sodium). Reports on generic versions are filed under their own applications.

Reports

2,033

Serious

189

9% of reports

Hospitalization

63

Death reported

9

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product use issue466
  • drug ineffective461
  • insomnia185
  • medication error133
  • product use in unapproved indication113
  • somnolence113
  • therapeutic response unexpected103
  • incorrect drug administration duration101
  • incorrect dose administered73
  • expired product administered61
  • drug ineffective for unapproved indication60
  • feeling abnormal59
  • underdose59
  • fatigue45
  • headache45

Reports by year received

View as table
YearReports
20102
2014184
2015521
2016358
2017225
2018236
2019246
202087
202154
202240
202321
202430
202515
202614

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,126 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
incorrect drug administration durationSignal10137.330.83,522
product use issueSignal46625.723.711,116
medication errorSignal13324.821.03,016
therapeutic response unexpectedSignal10323.819.72,227
expired product administeredSignal6119.014.91,023
drug ineffective for unapproved indicationSignal6011.38.8555
underdoseSignal598.46.5376
insomniaSignal1857.26.3992
somnolenceSignal1135.84.9449
product use in unapproved indicationSignal1134.73.9331
drug ineffectiveSignal4613.63.3929
incorrect dose administeredSignal733.32.6117
feeling abnormalSignal592.52.055
headache450.70.64
fatigue450.60.412

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.